Loading [Contrib]/a11y/accessibility-menu.js
General
COST-BENEFIT ANALYSIS OF THE BUSINESS JUDGMENT RULE: A CRITIQUE IN LIGHT OF THE FINANCIAL MELTDOWN
Tood M. Aman
This article recasts the prominent arguments for and against the business judgment rule as cost-benefit arguments.
General
SECONDARY CONSIDERATIONS: A STRUCTURED FRAMEWORK FOR PATENT ANALYSIS
Jonathan J. Darrow
This article brings together the divergent strands of the secondary considerations doctrine into a single, robust framework that might be further developed by future commentators and courts.
This paper argues that new biomedical technology, whose purpose is to prevent children from suffering from disease, should not be unduly hindered by regulations or restrictions on human clinical trials.
General
S.O.S. FROM THE FDA: A CRY FOR HELP IN THE WORLD OF UNREGULATED DIETARY SUPPLEMENTS
Joseph K. Dier
This comment examines the numerous American statutes and regulatory framework surrounding the dietary supplement industry and concludes there is a need for new legislation and solutions.
General
THE FUTURE OF HONEST SERVICES FRAUD
Jennifer I. Rowe
This comment suggests that further legislation is needed to delineate an acceptably clear standard for criminalizing nondisclosure of a conflict of interest.